Metabolic effects of rhIGF-1 in normal human subjects.
Rennert
N J
NJ
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.
Boulware
S D
SD
Kerr
D
D
Caprio
S
S
Tamborlane
W V
WV
Sherwin
R S
RS
D000328:Adult; D000818:Animals; D001364:Awareness; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D002096:C-Peptide / Q000097:blood*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005934:Glucagon / Q000097:blood*; D005947:Glucose / Q000378:metabolism; D015309:Glucose Clamp Technique; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007003:Hypoglycemia / Q000503:physiopathology; D007328:Insulin / Q000097:blood / Q000494:pharmacology; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D009638:Norepinephrine / Q000097:blood; D051381:Rats; D011994:Recombinant Proteins / Q000494:pharmacology
D001786:Blood Glucose; D002096:C-Peptide; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D011994:Recombinant Proteins; D007334:Insulin-Like Growth Factor I; D005934:Glucagon; D005947:Glucose; D009638:Norepinephrine